Clinical Trial Update: Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports population pharmacokinetics and Monte Carlo dosing simulations of meropenem in the early phase of severe sepsis and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Merrem (meropenem)

Snippet

Sponsor: Sutep Jaruratanasirikul | Conditions: Initial Phase of Severe Sepsis and Septic Shock | Phase 4 | Status: COMPLETED